SPHK1 and myocardial infarction: Conversely, significant increases in cardiac S1P, SphK1 and S1PR1 are observed in postmyocardial infarction (MI) associated with the proinflammatory response, and inhibition of this inflammatory pathway may benefit patients with MI [263].